高度 发表于 2025-3-25 07:22:34
Evolving Genomics of Pulmonary Fibrosis,uch technologies have been applied to lungs and cells of patients and animal models of disease with the goal of identifying key molecules with a role in pathogenesis or to develop biomarkers of disease presence, progression, and outcome as well as to identify potential drug targets. Genomics profili抵消 发表于 2025-3-25 09:23:38
http://reply.papertrans.cn/47/4611/461073/461073_22.pnganthesis 发表于 2025-3-25 13:04:39
http://reply.papertrans.cn/47/4611/461073/461073_23.png感染 发表于 2025-3-25 17:16:37
http://reply.papertrans.cn/47/4611/461073/461073_24.pngpropose 发表于 2025-3-25 23:33:30
http://reply.papertrans.cn/47/4611/461073/461073_25.pngDebrief 发表于 2025-3-26 01:12:50
Mimics of Idiopathic Pulmonary Fibrosis,te thoracic imaging, which in many cases may be sufficient to attain a confident diagnosis. In other cases, however, sampling of lung tissue might be necessary to confirm a usual interstitial pneumonia (UIP) histopathologic pattern if high-resolution computed tomography (HRCT) does not reveal a UIP即席 发表于 2025-3-26 07:35:49
http://reply.papertrans.cn/47/4611/461073/461073_27.pngParaplegia 发表于 2025-3-26 09:33:23
http://reply.papertrans.cn/47/4611/461073/461073_28.pnglocus-ceruleus 发表于 2025-3-26 14:53:46
http://reply.papertrans.cn/47/4611/461073/461073_29.png营养 发表于 2025-3-26 18:42:03
Lung Transplantation for Idiopathic Pulmonary Fibrosis,to resolve fibrosis or improve lung function in IPF. Lung transplantation therefore remains the only lifesaving therapy available to treat patients with IPF. A shortage of suitable donor organs limits the number of affected individuals who can undergo this procedure, highlighting the need to allocat